Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Roger Markwald and Suniti Misra.
Connection Strength

3.485
  1. Periostin/Filamin-A: A Candidate Central Regulatory Axis for Valve Fibrogenesis and Matrix Compaction. Front Cell Dev Biol. 2021; 9:649862.
    View in: PubMed
    Score: 0.819
  2. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through ?-catenin/MDR1 signaling to sustain chemoresistance. Front Oncol. 2022; 12:906260.
    View in: PubMed
    Score: 0.225
  3. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance. Front Oncol. 2022; 12:906415.
    View in: PubMed
    Score: 0.222
  4. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells. Int J Mol Sci. 2021 Jan 13; 22(2).
    View in: PubMed
    Score: 0.199
  5. Periostin/?1integrin interaction regulates p21-activated kinases in valvular interstitial cell survival and in actin cytoskeleton reorganization. Biochim Biophys Acta Gen Subj. 2019 05; 1863(5):813-829.
    View in: PubMed
    Score: 0.174
  6. Role of Periostin in Cardiac Valve Development. Adv Exp Med Biol. 2019; 1132:177-191.
    View in: PubMed
    Score: 0.173
  7. Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem. 2017 06 23; 292(25):10490-10519.
    View in: PubMed
    Score: 0.153
  8. Transforming growth factor ?1 (TGF?1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. J Biol Chem. 2017 06 23; 292(25):10465-10489.
    View in: PubMed
    Score: 0.153
  9. Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery. Int J Cell Biol. 2015; 2015:537560.
    View in: PubMed
    Score: 0.138
  10. Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis. Int J Cell Biol. 2015; 2015:834893.
    View in: PubMed
    Score: 0.138
  11. Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol. 2015; 6:201.
    View in: PubMed
    Score: 0.134
  12. Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer. Med Chem Res. 2014 Aug 01; 23(8):3836-3851.
    View in: PubMed
    Score: 0.127
  13. Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J Biol Chem. 2014 Mar 21; 289(12):8545-61.
    View in: PubMed
    Score: 0.123
  14. Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
    View in: PubMed
    Score: 0.122
  15. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011 May; 278(9):1429-43.
    View in: PubMed
    Score: 0.101
  16. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J Biol Chem. 2010 Jun 25; 285(26):19821-32.
    View in: PubMed
    Score: 0.094
  17. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE. J Biol Chem. 2009 May 01; 284(18):12432-46.
    View in: PubMed
    Score: 0.087
  18. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem. 2008 May 23; 283(21):14335-44.
    View in: PubMed
    Score: 0.082
  19. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer. Connect Tissue Res. 2008; 49(3):219-24.
    View in: PubMed
    Score: 0.081
  20. Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer. Connect Tissue Res. 2008; 49(3):265-9.
    View in: PubMed
    Score: 0.081
  21. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities. Bioorg Med Chem Lett. 2014 Jan 01; 24(1):317-24.
    View in: PubMed
    Score: 0.030
  22. miR-21 represses Pdcd4 during cardiac valvulogenesis. Development. 2013 May; 140(10):2172-80.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.